Company Number: 13538439

Analysis Date: 2025-07-20 17:09 UTC

Financial Health Assessment of STUDIO BDY LTD as of 31 July 2024

---

1. Financial Health Score: B

Explanation:
STUDIO BDY LTD demonstrates a solid financial foundation for a micro-entity with a growing asset base and healthy working capital. The company’s net current assets and shareholders’ funds have increased steadily over the past years, indicating good financial stability. However, as a micro company with limited scale and resources, there is room for improvement to further strengthen liquidity and capital structure.

---

2. Key Vital Signs

Metric	2024 Figure (£)	Interpretation
Fixed Assets	22,761	Moderate investment in long-term assets, up from £4,226 in 2023, showing reinvestment in infrastructure or equipment.
Current Assets	122,672	Healthy short-term resources, primarily cash or receivables, which support operational needs.
Current Liabilities	53,185	Obligations due within one year, increased modestly but manageable given asset levels.
Net Current Assets	69,487	Positive working capital, indicating the company can cover short-term debts comfortably.
Total Assets Less Current Liabilities	92,248	Reflects net assets, showing growth from prior year and a positive net asset position.
Shareholders’ Funds	92,248	Equity capital has grown, indicating retained earnings or capital injection.

Interpretation of Vital Signs:
The company’s working capital (net current assets) is healthy, like a patient with a strong pulse, indicating liquidity to meet short-term obligations without distress. The rise in fixed assets suggests reinvestment to support growth. The increase in shareholders’ funds is akin to a strengthening immune system, providing a buffer against financial shocks.

---

3. Diagnosis

STUDIO BDY LTD is financially sound with positive net assets and growing equity, showing resilience typical of a well-managed micro-entity. The company maintains a stable balance between current assets and liabilities, ensuring operational liquidity. The absence of overdue filings and timely confirmation statements reflect good governance and regulatory compliance, which supports business credibility.

There is no evidence of financial distress symptoms such as negative working capital, recurring losses, or creeping liabilities. The growth in fixed assets and equity suggests the business is reinvesting profits or capital to support ongoing activities and possibly expansion.

However, as a micro-entity with only two employees on average, the company’s scale limits its ability to absorb large shocks or invest heavily in growth initiatives. The departure of one director in February 2025 could be a point to monitor for management continuity.

---

4. Recommendations

• Maintain Strong Liquidity: Continue to monitor and manage working capital to ensure the company maintains a healthy cash flow buffer, avoiding symptoms of cash strain.
• Strategic Reinvestment: Assess the return on new fixed asset investments to ensure they contribute positively to profitability and operational efficiency.
• Governance Stability: Ensure clear succession or management plans are in place following the director’s resignation to avoid disruption in leadership.
• Growth Planning: Explore opportunities to scale operations carefully, considering market conditions and resource availability to avoid overextension.
• Financial Monitoring: Regularly review key financial metrics and cash flow forecasts to detect early signs of distress and respond proactively.
• Stakeholder Communication: Keep shareholders and key stakeholders informed about financial performance and strategic direction to maintain confidence.

---